Reker, Daniel http://orcid.org/0000-0003-4789-7380
Rybakova, Yulia
Kirtane, Ameya R. http://orcid.org/0000-0002-3779-0363
Cao, Ruonan
Yang, Jee Won http://orcid.org/0000-0002-3257-1823
Navamajiti, Natsuda
Gardner, Apolonia
Zhang, Rosanna M.
Esfandiary, Tina http://orcid.org/0000-0003-0091-6310
L’Heureux, Johanna
von Erlach, Thomas
Smekalova, Elena M.
Leboeuf, Dominique
Hess, Kaitlyn http://orcid.org/0000-0003-2837-0305
Lopes, Aaron
Rogner, Jaimie
Collins, Joy
Tamang, Siddartha M.
Ishida, Keiko
Chamberlain, Paul
Yun, DongSoo http://orcid.org/0000-0001-9495-1613
Lytton-Jean, Abigail http://orcid.org/0000-0002-1582-0066
Soule, Christian K.
Cheah, Jaime H.
Hayward, Alison M.
Langer, Robert http://orcid.org/0000-0003-4255-0492
Traverso, Giovanni http://orcid.org/0000-0001-7851-4077
Funding for this research was provided by:
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (P2EZP3_168827, P300P2_177833)
Skolkovo Institute of Science and Technology
Pharmaceutical Research and Manufacturers of America Foundation
U.S. Department of Health & Human Services | NIH | National Cancer Institute (Grant P30-CA14051, Grant P30-CA14051, Grant P30-CA14051, Grant P30-CA14051)
U.S. Department of Health & Human Services | National Institutes of Health (EB000244, EB000244)
Article History
Received: 29 September 2019
Accepted: 28 January 2021
First Online: 25 March 2021
Competing interests
: D.R., Y.R., A.R.K., R.C., J.W.Y., N.N., A.G., R.M.Z., R.L. and G.T. are co-inventors on multiple patent applications describing novel nanoformulation systems and interactions between excipients and drugs. D.R. acts as a mentor for the German Accelerator Life Sciences and acts as a scientific consultant for pharmaceutical and biotechnology companies.